RIGEL PHARMACEUTICALS, INC. Cost of Revenue
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Cost of Revenue of $8.53 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-04
- RIGEL PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $8.53M, a 89.28% increase year-over-year.
- RIGEL PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $4.61M, a 4.47% increase year-over-year.
- RIGEL PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $5.96M, a 2.87% increase year-over-year.
- RIGEL PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $4.75M, a 40.78% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2025 was $19.62M, a 5.22% increase from fiscal 2024.
- RIGEL PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2024 was $18.65M, a 162.26% increase from fiscal 2023.
- RIGEL PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2023 was $7.11M, a 306.52% increase from fiscal 2022.
- RIGEL PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2022 was $1.75M, a 61.50% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.53M 10-Q · filed 2026-08-04 | $13.13M 10-Q · filed 2026-08-04 | $19.09M derived: sum of 3 quarters · filed 2026-08-04 | $23.84M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $4.61M 10-Q · filed 2026-05-05 | $10.56M derived: sum of 2 quarters · filed 2026-05-05 | $15.31M derived: sum of 3 quarters · filed 2026-05-05 | $19.82M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $10.71M derived: sum of 2 quarters · filed 2026-03-03 | $15.21M derived: sum of 3 quarters · filed 2026-08-04 | $19.62M 10-K · filed 2026-03-03 |
| 2025-09-30 | $4.75M 10-Q · filed 2025-11-04 | $9.26M derived: sum of 2 quarters · filed 2026-08-04 | $13.67M 10-Q · filed 2025-11-04 | $19.45M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $4.50M 10-Q · filed 2026-08-04 | $8.91M 10-Q · filed 2026-08-04 | $14.70M derived: sum of 3 quarters · filed 2026-08-04 | $22.73M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $4.41M 10-Q · filed 2026-05-05 | $10.20M derived: sum of 2 quarters · filed 2026-05-05 | $18.22M derived: sum of 3 quarters · filed 2026-05-05 | $21.03M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $13.81M derived: sum of 2 quarters · filed 2026-03-03 | $16.62M derived: sum of 3 quarters · filed 2026-03-03 | $18.65M 10-K · filed 2026-03-03 |
| 2024-09-30 | $8.03M 10-Q · filed 2025-11-04 | $10.83M derived: sum of 2 quarters · filed 2025-11-04 | $12.86M 10-Q · filed 2025-11-04 | $16.65M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $2.81M 10-Q · filed 2025-08-05 | $4.83M 10-Q · filed 2025-08-05 | $8.62M derived: sum of 3 quarters · filed 2026-03-03 | $9.89M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $2.02M 10-Q · filed 2025-05-06 | $5.82M derived: sum of 2 quarters · filed 2026-03-03 | $7.08M derived: sum of 3 quarters · filed 2026-03-03 | $8.16M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $5.06M derived: sum of 2 quarters · filed 2026-03-03 | $6.13M derived: sum of 3 quarters · filed 2026-03-03 | $7.11M 10-K · filed 2026-03-03 |
| 2023-09-30 | $1.27M 10-Q · filed 2024-11-07 | $2.34M derived: sum of 2 quarters · filed 2024-11-07 | $3.32M 10-Q · filed 2024-11-07 | $3.66M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $1.07M 10-Q · filed 2024-08-06 | $2.05M 10-Q · filed 2024-08-06 | $2.39M derived: sum of 3 quarters · filed 2025-03-04 | $2.64M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $977.00K 10-Q · filed 2024-05-07 | $1.32M derived: sum of 2 quarters · filed 2025-03-04 | $1.57M derived: sum of 3 quarters · filed 2025-03-04 | $2.60M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $592.00K derived: sum of 2 quarters · filed 2025-03-04 | $1.63M derived: sum of 3 quarters · filed 2025-03-04 | $1.75M 10-K · filed 2025-03-04 |
| 2022-09-30 | $250.00K 10-Q · filed 2023-11-07 | $1.29M derived: sum of 2 quarters · filed 2023-11-07 | $1.41M 10-Q · filed 2023-11-07 | $1.89M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $1.04M 10-Q · filed 2023-08-01 | $1.16M 10-Q · filed 2023-08-01 | $1.64M derived: sum of 3 quarters · filed 2024-03-05 | $1.79M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $121.00K 10-Q · filed 2023-05-02 | $608.00K derived: sum of 2 quarters · filed 2024-03-05 | $759.00K derived: sum of 3 quarters · filed 2024-03-05 | $888.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $638.00K derived: sum of 2 quarters · filed 2024-03-05 | $767.00K derived: sum of 3 quarters · filed 2024-03-05 | $1.08M 10-K · filed 2024-03-05 |
| 2021-09-30 | $151.00K 10-Q · filed 2022-11-03 | $280.00K derived: sum of 2 quarters · filed 2022-11-03 | $596.00K 10-Q · filed 2022-11-03 | $917.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $129.00K 10-Q · filed 2022-08-02 | $445.00K 10-Q · filed 2022-08-02 | $766.00K derived: sum of 3 quarters · filed 2023-03-07 | $906.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $316.00K 10-Q · filed 2022-05-03 | $637.00K derived: sum of 2 quarters · filed 2023-03-07 | $777.00K derived: sum of 3 quarters · filed 2023-03-07 | $1.06M derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $461.00K derived: sum of 2 quarters · filed 2023-03-07 | $740.00K derived: sum of 3 quarters · filed 2023-03-07 | $895.00K 10-K · filed 2023-03-07 |
| 2020-09-30 | $140.00K 10-Q · filed 2021-11-02 | $419.00K derived: sum of 2 quarters · filed 2021-11-02 | $574.00K 10-Q · filed 2021-11-02 | $752.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $279.00K 10-Q · filed 2021-08-03 | $434.00K 10-Q · filed 2021-08-03 | $612.00K derived: sum of 3 quarters · filed 2022-03-01 | $922.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $155.00K 10-Q · filed 2021-05-05 | $333.00K derived: sum of 2 quarters · filed 2022-03-01 | $643.00K derived: sum of 3 quarters · filed 2022-03-01 | $954.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $488.00K derived: sum of 2 quarters · filed 2022-03-01 | $799.00K derived: sum of 3 quarters · filed 2022-03-01 | $906.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $310.00K 10-Q · filed 2020-11-05 | $621.00K derived: sum of 2 quarters · filed 2020-11-05 | $728.00K 10-Q · filed 2020-11-05 | $916.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | $311.00K 10-Q · filed 2020-08-04 | $418.00K 10-Q · filed 2020-08-04 | $606.00K derived: sum of 3 quarters · filed 2021-03-02 | $675.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | $107.00K 10-Q · filed 2020-05-05 | $295.00K derived: sum of 2 quarters · filed 2021-03-02 | $364.00K derived: sum of 3 quarters · filed 2021-03-02 | $394.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $257.00K derived: sum of 2 quarters · filed 2021-03-02 | $287.00K derived: sum of 3 quarters · filed 2021-03-02 | $287.00K 10-K · filed 2021-03-02 |
| 2018-09-30 | $69.00K 10-Q · filed 2019-11-05 | $99.00K derived: sum of 2 quarters · filed 2019-11-05 | $99.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $30.00K 10-Q · filed 2019-08-06 | $30.00K 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |